|||
di-ethylstilbestrolsyndroom bij foetus (aandoening)
DES-syndroom bij foetus
di-ethylstilbestrolsyndroom bij foetus
foetaal di-ethylstilbestrolsyndroom
foetaal syndroom door di-ethylstilbestrol
Fetal diethylstilbestrol syndrome
Foetal diethylstilbestrol syndrome
Distilbene embryofetopathy
DES (diethylstilbestrol) syndrome
A malformation syndrome reported in offspring (children and grandchildren) of women exposed to diethylstilbestrol (DES) during pregnancy and is characterized by reproductive tract malformations, decreased fertility and increased risk of developing clear cell carcinoma of the vagina and cervix in young women. Reproductive malformations reported in DES syndrome include small, T-shaped uteri and other uterotubal anomalies that increase the risk of miscarriages in women and epididymal cysts, microphallus, cryptorchidism, or testicular hypoplasia in men. DES, a synthetic nonsteroidal estrogen was widely prescribed from 1940-1970 to prevent miscarriage.
Id716005004
StatusDefined
Associated morphologymorfologische afwijking
Causative agentdi-ethylstilbestrol
Occurrencefoetale periode
Pathological processproces van pathologische ontwikkeling
DHD Diagnosis thesaurus reference set
RIVM authorized national diagnosis thesaurus to ICD10 complex mapping reference set
TargetQ86.8
TermOverige congenitale gestoorde-ontwikkelingssyndromen door bekende exogene oorzaken
SNOMED CT to Orphanet simple map1916
SNOMED CT to ICD-10 extended map
TargetQ86.8
RuleTRUE
AdviceALWAYS Q86.8 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
CorrelationSNOMED CT source code to target map code correlation not specified